adenosine A1 receptor antagonists

Preferred Label : adenosine A1 receptor antagonists;

MeSH definition : Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS.;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058916;

UMLS CUI

C2936569;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 2-amino-8-(2-morpholinoethoxy)-4-phenyl-5H-indeno(1,2-d)pyrimidin-5-one [MeSH Supplementary Concept]
- 2-amino-8-(4-methylpiperazine-1-carbonyl)-4-phenyl-5H-indeno(1,2-d)pyrimidin-5-one [MeSH Supplementary Concept]
- 7-methyl-1-phenyl-1,8-dihydropyrazolo(3,4d)(1,2,4)-triazolo(1,5a)pyrimidin-4-one [MeSH Supplementary Concept]
MeSH Descriptor(s) used for indexing
- receptor, adenosine a1 [MeSH Descriptor]
Record concept(s)
- adenosine A1 receptor antagonists [MeSH concept]
See also (suggested by CISMeF)
- receptor, adenosine a1 [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine [MeSH Supplementary Concept]
- 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine [MeSH Supplementary Concept]
- 1,3-dipropyl-8-cyclopentylxanthine [MeSH Supplementary Concept]
- 1-butyl-3-(3-hydroxypropyl)-8-(3-noradamantyl)xanthine [MeSH Supplementary Concept]
- 1-butyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine [MeSH Supplementary Concept]
- 1-propyl-8-(4-((4-nitrophenoxy)sulfonyl)phenyl)xanthine [MeSH Supplementary Concept]
- 2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-3(2H)-pyridazinone [MeSH Supplementary Concept]
- 2-amino-4-(3-trifluoromethylphenyl)-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile [MeSH Supplementary Concept]
- 3,4',5-tri(glucose-3-O-succinyl)resveratrol [MeSH Supplementary Concept]
- 3-(2-(4-aminophenyl)ethyl)-8-benzyl-7-(2-ethyl(2-hydroxyethyl)aminoethyl)-1-propyl-3,7-dihydropurine-2,6-dione [MeSH Supplementary Concept]
- 5-(5-amino-3-(4-fluorophenyl)pyrazin-2-yl)-1-isopropylprydine-2(1H)-one [MeSH Supplementary Concept]
- 5-N-methylimino-2-(3-methylphenyl)-3-phenyl-2H-(1,2,4)-thiadiazole [MeSH Supplementary Concept]
- 7,8-dihydro-8-ethyl-2-(4-bicyclo(2.2.2)octan-1-ol)-4-propyl-1H-imidazo(2,1-i)purin-5(4H)-one [MeSH Supplementary Concept]
- 7-chloro-4-hydroxy-2-phenyl-1,8-naphthyridine [MeSH Supplementary Concept]
- 8-cyclopentyl-2,6-diphenylpurine [MeSH Supplementary Concept]
- 8-cyclopentyl-3-(3-iodoprop-2-en-1-yl)-1-propylxanthine [MeSH Supplementary Concept]
- 9-butyl-2-(3-noradamantyl)-4,5-dihydro-6H,8H-pyrimido(1,2,3-cd)purine-8,10-dione [MeSH Supplementary Concept]
- N-(4,6-diphenylpyrimidin-2-yl)butyramide [MeSH Supplementary Concept]
- isopropyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate [MeSH Supplementary Concept]
- methyl 1-(2-chloro-2-phenylethyl)-4-((2-(4-methoxyphenyl)ethyl)amino)-1H-pyrazolo(3,4-b)pyridine-5-carboxylate [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients